Equity Overview
Price & Market Data
Price: $0.032
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $86,459,712
Daily Volume: 0
Performance Metrics
1 Week: -0.47%
1 Month: -0.47%
3 Months: 966.7%
6 Months: 99.38%
1 Year: 1,085%
YTD: 966.7%
Details
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.